Zoetis | ZTS - Des Atouts

Prix De L'Action
119.23
Variation Quotidienne
1.37 1.16%
Mensuellement
0.91%
Annuel
-20.95%
Q2 Prévisions
114.64




Des Atouts Changement Date
AbbVie USD 133.96B 62M 2025-12
Align Technology USD 6.23B 141K 2025-12
Bayer EUR 104.54B 331M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Charles River Laboratories USD 7.14B 378.39M 2025-12
Coherus Biosciences USD 258.34M 258.18M 2025-12
Dentsply International USD 5.43B 224M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Henry Schein USD 11.22B 118M 2025-12
Idexx Laboratories USD 3.35B 35.95M 2025-12
Illumina USD 6.64B 467M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
J&J USD 199.21B 6.39B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Merck USD 129.55B 12.02B 2025-09
Neogen USD 3.36B 953K 2025-12
Pacira USD 1.26B 32.66M 2025-12
Perrigo USD 8.54B 1.55B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Phibro Animal Health USD 1.41B 20.03M 2025-12
Quest Diagnostics USD 16.23B 28M 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Sanofi EUR 126.81B 25.48B 2025-12
Zoetis USD 15.47B 308M 2025-12